Cowen and Company advice for Amgen
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| January 03, 2014 | Cowen and Company | Amgen | Buy | 129.00 USD |
Advice details
New York - Op 03 Jan 2014 herhalen de analisten van Cowen and Company hun koopadvies voor the American bio-technology company Amgen (ISIN: US0311621009 / Mnemo: AMGN). Het 12-maands koersdoel is vastgesteld op 129.0 USD
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 